Diagnosis and management of typical and atypical lung carcinoids

Sara Pusceddu; Giuseppe Lo Russo; Marianna Macerelli; Claudia Proto; Milena Vitali; Diego Signorelli; Monica Ganzinelli; Paolo Scanagatta; Leonardo Duranti; Annalisa Trama; Roberto Buzzoni; Giuseppe Pelosi; Ugo Pastorino; Filippo de Braud; Marina Chiara Garassino

doi:10.1016/j.critrevonc.2016.02.009

Diagnosis and management of typical and atypical lung carcinoids

Sara Pusceddu, Giuseppe Lo Russo, Marianna Macerelli, Claudia Proto, Milena Vitali, Diego Signorelli, Monica Ganzinelli, Paolo Scanagatta, Leonardo Duranti, Annalisa Trama, Roberto Buzzoni, Giuseppe Pelosi, Ugo Pastorino, Filippo de Braud, Marina Chiara Garassino

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Article › peer-review

Abstract

An estimated 20% to 30% of all neuroendocrine tumours originate in the bronchial tree and lungs. According to the 2015 World Health Organization categorization, these tumours are separated into four subtypes characterized by increasing biological aggressiveness: typical carcinoid, atypical carcinoid, large-cell neuroendocrine carcinoma and small-cell carcinoma. Although typical and atypical lung carcinoids account for less than 1-5% of all pulmonary malignancies, the incidence of these neoplasms has risen significantly in recent decades. Surgery is the treatment of choice for loco-regional disease but for advanced lung carcinoids there is no recognized standard of care and successful management requires a multidisciplinary approach. The aim of this review is to provide a useful guide for the clinical management of lung carcinoids.

Original language	English
Pages (from-to)	167-176
Number of pages	10
Journal	Critical Reviews in Oncology/Hematology
Volume	100
DOIs	https://doi.org/10.1016/j.critrevonc.2016.02.009
Publication status	Published - Apr 1 2016

Keywords

Atypical carcinoids
Lung carcinoids
Neuroendocrine tumours
Typical carcinoids

ASJC Scopus subject areas

Oncology
Hematology
Geriatrics and Gerontology

Access to Document

10.1016/j.critrevonc.2016.02.009

Cite this

Pusceddu, S., Lo Russo, G., Macerelli, M., Proto, C., Vitali, M., Signorelli, D., Ganzinelli, M., Scanagatta, P., Duranti, L., Trama, A., Buzzoni, R., Pelosi, G., Pastorino, U., de Braud, F., & Garassino, M. C. (2016). Diagnosis and management of typical and atypical lung carcinoids. Critical Reviews in Oncology/Hematology, 100, 167-176. https://doi.org/10.1016/j.critrevonc.2016.02.009

Pusceddu, S, Lo Russo, G, Macerelli, M, Proto, C, Vitali, M, Signorelli, D, Ganzinelli, M , Scanagatta, P , Duranti, L , Trama, A, Buzzoni, R, Pelosi, G , Pastorino, U , de Braud, F & Garassino, MC 2016, 'Diagnosis and management of typical and atypical lung carcinoids', Critical Reviews in Oncology/Hematology, vol. 100, pp. 167-176. https://doi.org/10.1016/j.critrevonc.2016.02.009

@article{56e2ffbb7024413bb1efcf092a57ad22,

title = "Diagnosis and management of typical and atypical lung carcinoids",

abstract = "An estimated 20% to 30% of all neuroendocrine tumours originate in the bronchial tree and lungs. According to the 2015 World Health Organization categorization, these tumours are separated into four subtypes characterized by increasing biological aggressiveness: typical carcinoid, atypical carcinoid, large-cell neuroendocrine carcinoma and small-cell carcinoma. Although typical and atypical lung carcinoids account for less than 1-5% of all pulmonary malignancies, the incidence of these neoplasms has risen significantly in recent decades. Surgery is the treatment of choice for loco-regional disease but for advanced lung carcinoids there is no recognized standard of care and successful management requires a multidisciplinary approach. The aim of this review is to provide a useful guide for the clinical management of lung carcinoids.",

keywords = "Atypical carcinoids, Lung carcinoids, Neuroendocrine tumours, Typical carcinoids",

author = "Sara Pusceddu and {Lo Russo}, Giuseppe and Marianna Macerelli and Claudia Proto and Milena Vitali and Diego Signorelli and Monica Ganzinelli and Paolo Scanagatta and Leonardo Duranti and Annalisa Trama and Roberto Buzzoni and Giuseppe Pelosi and Ugo Pastorino and {de Braud}, Filippo and Garassino, {Marina Chiara}",

year = "2016",

month = apr,

day = "1",

doi = "10.1016/j.critrevonc.2016.02.009",

language = "English",

volume = "100",

pages = "167--176",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Diagnosis and management of typical and atypical lung carcinoids

AU - Pusceddu, Sara

AU - Lo Russo, Giuseppe

AU - Macerelli, Marianna

AU - Proto, Claudia

AU - Vitali, Milena

AU - Signorelli, Diego

AU - Ganzinelli, Monica

AU - Scanagatta, Paolo

AU - Duranti, Leonardo

AU - Trama, Annalisa

AU - Buzzoni, Roberto

AU - Pelosi, Giuseppe

AU - Pastorino, Ugo

AU - de Braud, Filippo

AU - Garassino, Marina Chiara

PY - 2016/4/1

Y1 - 2016/4/1

N2 - An estimated 20% to 30% of all neuroendocrine tumours originate in the bronchial tree and lungs. According to the 2015 World Health Organization categorization, these tumours are separated into four subtypes characterized by increasing biological aggressiveness: typical carcinoid, atypical carcinoid, large-cell neuroendocrine carcinoma and small-cell carcinoma. Although typical and atypical lung carcinoids account for less than 1-5% of all pulmonary malignancies, the incidence of these neoplasms has risen significantly in recent decades. Surgery is the treatment of choice for loco-regional disease but for advanced lung carcinoids there is no recognized standard of care and successful management requires a multidisciplinary approach. The aim of this review is to provide a useful guide for the clinical management of lung carcinoids.

AB - An estimated 20% to 30% of all neuroendocrine tumours originate in the bronchial tree and lungs. According to the 2015 World Health Organization categorization, these tumours are separated into four subtypes characterized by increasing biological aggressiveness: typical carcinoid, atypical carcinoid, large-cell neuroendocrine carcinoma and small-cell carcinoma. Although typical and atypical lung carcinoids account for less than 1-5% of all pulmonary malignancies, the incidence of these neoplasms has risen significantly in recent decades. Surgery is the treatment of choice for loco-regional disease but for advanced lung carcinoids there is no recognized standard of care and successful management requires a multidisciplinary approach. The aim of this review is to provide a useful guide for the clinical management of lung carcinoids.

KW - Atypical carcinoids

KW - Lung carcinoids

KW - Neuroendocrine tumours

KW - Typical carcinoids

UR - http://www.scopus.com/inward/record.url?scp=84960373477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960373477&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2016.02.009

DO - 10.1016/j.critrevonc.2016.02.009

M3 - Article

AN - SCOPUS:84960373477

VL - 100

SP - 167

EP - 176

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

ER -

Diagnosis and management of typical and atypical lung carcinoids

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this